Serological immune response against ADAM10 pro-domain is associated with favourable prognosis in stage III colorectal cancer patients-Reference-Cited by-同舟云学术

Serological immune response against ADAM10 pro-domain is associated with favourable prognosis in stage III colorectal cancer patients

Published:2016-08-10 Issue:48 Volume:7 Page:80059-80076
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Álvarez-Fernández Sheila María¹,Barbariga Marco¹²,Cannizzaro Luca¹³,Cannistraci Carlo Vittorio⁴,Hurley Laura¹⁵,Zanardi Alan¹,Conti Antonio¹,Sanvito Francesca⁶,Innocenzi Anna⁶,Pecorelli Nicolò⁷,Braga Marco⁷,Alessio Massimo¹

Affiliation:

1. Proteome Biochemistry, IRCCS-San Raffaele Scientific Institute, Milan, Italy

2. Translational Neurology group, Wallenberg Neuroscience Center, BMC, Lund, Sweden

3. Systems Biology Center, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

4. Biomedical Cybernetics Group, Biotechnology Center (BIOTEC), Center for Molecular and Cellular Bioengineering (CMCB), Technische Universität Dresden, Dresden, Germany

5. Wayne State University, School of Medicine, Cancer Biology PhD Program, Detroit, Michigan, USA

6. Pathology, IRCCS-San Raffaele Scientific Institute, Milan, Italy

7. Department of Surgery, Vita-Salute San Raffaele University, Milan, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoantibodies in cancer: a systematic review of their clinical role in the most prevalent cancers;Frontiers in Immunology;2024-08-21

2. B cell clonality in cancer;Seminars in Immunology;2024-03

3. Autoantibodies in laryngeal cancer: detection and role as a biomarker;Laboratory Medicine;2024-02-13

4. Pilot proteomic study of locally advanced rectal cancer before and after neoadjuvant chemoradiotherapy indicates high metabolic activity in non‐responders' tumor tissue;PROTEOMICS – Clinical Applications;2022-09-07

5. ADAM10 Site-Dependent Biology: Keeping Control of a Pervasive Protease;International Journal of Molecular Sciences;2021-05-07